U.S. blacks five times as likely as whites to progress to kidney failure

October 21, 2003

It's long been known that black Americans are four to five times as likely as white Americans to suffer from kidney disease that is severe enough to require dialysis or transplantation. Now a new study conducted by researchers at the University of California, San Francisco (UCSF) and San Francisco VA Medical Center (SFVAMC) shows that rates of early kidney disease do not differ between the two groups, but that blacks with early disease are five times as likely as whites to progress to the severe stage that requires dialysis or transplantation. The findings suggest that black Americans with early kidney disease require much more aggressive treatment than has been commonly practiced.

"Black Americans make up a third of the dialysis population, but only about a tenth of the overall population. But nobody has ever looked at whether blacks have more early kidney disease than whites," says Chi-yuan Hsu, MD, lead author of the study and an assistant professor of medicine at UCSF. "What we found is that the two groups have the same amount of kidney disease, but if someone has early disease and they are white, their chances of going to dialysis are one in 100 per year. But if they are black, their chance is five times higher."

The study appears in November's Journal of the American Society of Nephrology. Senior investigator in the study is Michael Shlipak, MD, MPH, assistant professor of medicine, epidemiology and biostatistics at SFVAMC and UCSF.

In the United States, the two major risk factors for kidney disease are uncontrolled diabetes and hypertension (high blood pressure). Early kidney disease, also called chronic renal insufficiency, is a gradually progressing disease that if left untreated can result in end-stage renal disease, the point at which kidneys fail. Without a kidney transplant or dialysis -- a blood-filtering process that must be performed several times a week -- a person suffering from end-stage kidney disease will die. Although statistics for end-stage kidney disease and its treatments are tracked through a comprehensive national registry (the U.S. Renal Data System), early-stage kidney disease can go undetected for years, making its onset and progression difficult to detect.

In order to determine the prevalence of the earlier stages of disease, Hsu and his team turned to a national health survey conducted periodically by the Centers for Disease Control called NHANES, or the National Health and Nutrition Examination Survey. The survey uses interviews and a battery of tests to assess the health of a representative sample of people across the country. Survey results are then extrapolated to the U.S. population as a whole.

Using records from blood tests drawn during the 1988-1994 survey, Hsu and his team used a formula to estimate the glomerular infiltration rate -- a measure of kidney function -- of each of the survey's black and white participants aged 20 to 74, a total of 13,351 people. They found that about 2 percent of blacks and 2.5 percent of whites had early kidney disease, a difference that was not statistically significant. To estimate how many people progressed to end-stage kidney disease five years later, they examined U.S. Renal Data System records for the number of new cases of end-stage kidney disease that arose in 1996 among black and white adults 25 to 79 years old. They found that for each 100 white people identified as having early kidney disease in 1991 (the mid-point of the NHANES survey), one went on to develop end-stage disease in 1996. But for each 100 black people with early kidney disease in 1991, five developed end-stage disease in 1996.

"We were very surprised to find that blacks didn't have more early kidney disease than whites," Hsu says. "We thought we would find that they had more kidney disease at all the stages."

Black Americans are more than twice as likely as white Americans to have hypertension, and one-and-a-half to two times as likely to have diabetes. Hsu found that black participants with early kidney disease in the NHANES survey had higher blood pressure than whites, with average systolic and diastolic pressures of 147 and 82, versus 136 and 77. Yet he also found that diabetic blacks and white survey participants with early kidney disease had similar blood sugar levels (an indication of how well diabetes is being controlled). Differences in blood pressure are unlikely to completely explain the five times higher rate of progression to end-stage disease, Hsu says. "We don't know the causes for this disparity," he says. "It could be quality of care and access to health care." A genetic component can't be ruled out, either, he says.

Based on this study's findings, Hsu and colleagues suggest that the National Kidney Foundation modify its Chronic Kidney Disease classification system to take into account the risk of progression of the disease. Right now a black person and a white person with chronic renal insufficiency would both be classified as having stage 3 or 4 chronic kidney disease. "But the implications of suffering stage 3 or 4 disease are very different for blacks and whites," Hsu says. "Our study suggests that a black person even with mild kidney disease should be treated much more aggressively. They should certainly attain at least as good blood pressure control, and they may need much more close monitoring and follow-up. The disparities we found in blood pressure control and progression rate from early to end-stage kidney disease must be addressed."

More than 400,000 Americans with end-stage renal disease are being treated by dialysis. With the country's population growing older and rates of diabetes soaring in large part due to increasing incidence of obesity, this number has more than doubled in the past decade, and is projected to grow to 650,000 by 2010, costing the Medicare system alone $28 billion.
-end-
Other investigators in the study were Feng Lin, MS, and Eric Vittinghoff, PhD, both from the department of Epidemiology and Biostatistics at UCSF. The study was funded by the National Institutes of Health and the Department of Veterans Affairs.

University of California - San Francisco

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.